There are many parallels between the different organisms. The Human Genome Project has been hijacked by free enterprise. Celera's participation probably means that the sequence will be known 2 or 3 years ahead of schedule. There is more interest in knowing the differences between individuals than in knowing the basic gene sequence. Different samples, especially from isolated populations, will be very important.
Pharmaceutical companies are also interested in the differences.
One of the keys will be trying to ensure public access to this information. If you can hold 1000 mice, you will see mutations. In Australia the cost of mouse production is less than in the USA and Europe. That puts us in a very competitive position to conduct these kinds of studies.